Hanmi Pharmaceutical Stock Resilient Despite Profit Dip: Key Insight Hanmi Pharmaceutical stock is discounted by governance and K-bio sentiment, but earnings remain resilient with net income up 6.8% YoY; analysts see Buy with 51% upside to the 624,615 won average target. 2026년 07월 09일 English
Samsung SDI Stock Slumps But Signals Improve: Buy Case Samsung SDI is a buy as revenue rose 12.6% YoY and losses shrank; ESS and solid-state/EV traction may stabilize earnings despite EV pricing pressure. 2026년 07월 08일 English
Kakao Earnings Hold Up as Stock Slides: Investor Insight Kakao shares are falling despite solid revenue growth and a 66 percent jump in operating profit; AI monetization doubts and weak net-income conversion keep sentiment and targets subdued. 2026년 07월 08일 English
Hanwha Ocean Earnings Jump After Submarine Program Loss: Buy Insight Hanwha Ocean shares plunged after Canada picked Germany for its next submarine program, but earnings surged year over year and it remains a reserve supplier, so the selloff may be an overreaction. 2026년 07월 07일 English
Samsung Biologics Profit Improves Yet Stock Undervalued: Why Samsung Biologics is rated Buy as strong margins and revenue growth persist despite labor disruption fears, leaving the stock below the average analyst target. 2026년 07월 07일 English
LG Energy Solution Stock Slumps Despite US ESS Growth: Key Insight LG Energy Solution stock is a Buy as earnings and margins are weak, but US ESS momentum, improved credits, and Ohio production ramps may stabilize gross profit within 6 to 18 months. 2026년 07월 06일 English
Korea Aerospace Industries Buyable Pullback as Earnings Soar – Key Export Insight Korea Aerospace Industries is rated Buy as export-driven earnings surged: revenue up 56.3% and operating profit up 43.4% YoY, with targets implying about 17% upside despite governance and labor risks. 2026년 07월 06일 English
Celltrion Earnings Soar – Strong Growth and Margin Upside Celltrion shows strong revenue growth and accelerating profits, driven by higher margin product mix and improving costs, supporting a bullish Buy consensus. 2026년 07월 03일 English
Hyundai Mobis Stock Moves Up Despite Earnings Volatility: Key Insight Hyundai Mobis trades as a Buy: revenue and operating profit are rising, but net income fell, likely from one off effects; analyst targets imply upside if earnings stabilize. 2026년 07월 03일 English
HD Hyundai Heavy Industries Earnings Jump: Valuation Re-Rates HD Hyundai Heavy Industries earns strong YoY growth and high margins, but labor and contract risks plus macro sentiment keep the stock undervalued; analysts rate it Buy. 2026년 07월 02일 English
